abs238.txt	objective		to	evaluate	blue-light	flexible	cystoscopy	(blfc)	withhexaminolevulinate	in	the	office	surveillance	of	patients	withnon-muscle-invasive	bladder	cancer	with	a	high	risk	of	recurrence	by	assessingits	impact	on	pain		anxiety		subjective	value	of	the	test	and	patient	willingnessto	pay	materials	and	methods		a	prospective		multicentre		phase	iii	study	was	conductedduring	which	the	patient-reported	outcomes	measurement	information	system(promis)	anxiety		pain	and	'was	it	worth	it'	questionnaires	were	administered	atbaseline		after	surveillance	with	blfc	and	after	resection	for	those	referred	tothe	operating	room		comparisons	of	scores	were	performed	between	groups	results		a	total	of	304	patients	were	enrolled		of	whom	103	were	referred	forsurgical	examination		of	these		63	were	found	to	have	histologically	confirmedmalignancy		pain	levels	were	low	throughout	the	study		anxiety	levels	decreasedafter	blfc	(âˆ†	=	-2	6)		with	a	greater	decrease	among	those	with	negativepathology	results	(p	=	0	051)		no	differences	in	anxiety	were	noted	based	ongender		blfc	results		or	test	performance	(true-positive/false-positive)		mostpatients	found	blfc	'worthwhile'	(94%)		would	'do	it	again'	(94%)	and	'wouldrecommend	it	to	others'	(91%)		with	no	differences	based	on	blfc	results	or	testperformance		most	patients	undergoing	blfc	(76%)	were	willing	to	pay	out	ofpocket	conclusions		anxiety	decreased	after	blfc	in	patients	with	negative	pathology	including	patients	with	false-positive	results		most	of	the	patients	undergoingblfc	were	willing	to	pay	out	of	pocket		found	the	procedure	worthwhile	and	wouldrecommend	it	to	others		irrespective	of	whether	they	had	a	positive	blfc	resultor	whether	this	was	false-positive	after	surgery	
